8 Stocks on Jim Cramer’s Mad Money Recap: IBM, Corning, and AI Rally Strength

Cramer argued the AI build-out remains strong enough to keep stocks higher, framing it as an economy-wide growth engine tied to NVIDIA’s Jensen Huang and the broader AI supply chain. He also highlighted Becton Dickinson’s strong quarter, with a top- and bottom-line beat, raised full-year earnings guidance, and a nearly 6% stock gain. Separately, he reiterated a bullish view on Agnico Eagle as a gold hedge, though he said he is not currently bullish on gold overall.

Analysis

The market is still treating AI capex as a straight-line winner, but the more interesting second-order effect is industrial re-rating outside semis: the build-out shifts spending toward mission-critical components, healthcare automation, power management, and mission support rather than pure software leverage. That makes BDX a cleaner expression of “AI as productivity infrastructure” than the usual headline names, because its earnings are being helped by labor substitution in hospitals — a multi-year theme with visible procurement budgets and less valuation fragility than pure AI beneficiaries.

AEM is the clearest counterweight in the set. If AI optimism keeps equities bid and real rates stop falling, gold can remain a crowded hedge that underperforms on a 3-6 month horizon; that creates a useful hedge pair against the broader risk-on AI complex. The deeper read is that AI capex may be structurally inflationary for select inputs — power, grid hardware, cooling, and advanced components — even if headline consumer demand softens, which favors capital-goods and infrastructure names more than cyclicals exposed to discretionary spending.

Consensus is probably overestimating how much of this theme is already priced into NVDA and underestimating how slowly the second-order beneficiaries re-rate. The AI “cake” narrative can support multiples for months, but the near-term catalyst path is earnings revisions and backlog conversion, not just story flow. The risk is that if rates back up or enterprise budgets get delayed, the market will punish anything with AI multiple expansion faster than it rewards the lagging infrastructure winners.

Key Decisions for Investors

• Go long BDX on pullbacks over the next 1-2 weeks; target a 6-12 month hold. Risk/reward favors a defensive growth compounder with an AI-enabled productivity tailwind and lower multiple compression risk than pure AI names.
• Use AEM as a tactical hedge against the AI-led risk-on tape: buy 3-6 month puts or short against a basket of AI beneficiaries. If real yields rise, AEM should outperform defensives; if AI momentum persists, the cost of carry is manageable.
• Reduce/additionally hedge crowded NVDA exposure with a call spread rather than outright sale; the name can still grind higher, but upside is increasingly dependent on order conversion versus narrative. Best entry is on post-earnings or market-wide weakness.
• Pair trade: long BDX / short a high-multiple consumer healthcare name over 3-6 months. The thesis is that enterprise productivity spend is proving more durable than consumer demand, and BDX has a clearer monetization path.
• Watch for a rotation into industrial electrification and power infrastructure if AI capex accelerates further; use any broader market dip to accumulate ETN on a 6-12 month horizon as a secondary beneficiary of data-center power demand.